載入...
Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages
Objective: The objective of this study was to investigate the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on renal function in different stages of chronic kidney disease (CKD).Design and Methods: We conducted a retrospective cohort study using longitudinal claims data from May 2016–...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2019-11-01
|
| 叢編: | Frontiers in Endocrinology |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/article/10.3389/fendo.2019.00820/full |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|